Humana Inc. Q3 2025 Earnings Recap

HUM Q3 2025 November 5, 2025

Get alerts when HUM reports next quarter

Humana delivered a solid performance in Q3 2025, maintaining its full-year EPS outlook of approximately $17 while executing effectively amid evolving market conditions.

Earnings Per Share Beat

$3.24 vs $2.93 est.

+10.6% surprise

Revenue Beat

32649000000 vs 31997441844 est.

+2.0% surprise

Market Reaction

1-Day -5.22%

5-Day -9.23%

30-Day -3.23%

See HUM alongside your other holdings

Add to your portfolio — free

Key Takeaways

Medical cost trends are in line with expectations, supporting ongoing profitability.
Medicare new sales are trending at the high end of anticipated ranges, with improved channel mix contributing to enhanced customer lifetime value.
The company is focused on reducing voluntary attrition through stable benefit strategies and enhanced customer service, showing favorable early indicators in the AEP.
Stars performance shows operational gains, with significant year-over-year improvements expected in key metrics for bonus year '28.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit HUM on AllInvestView.

Previous Q2 2025

Next Q1 2026